GlySure Inks $13.6M Series C

GlySure Limited, a developer of in-hospital continuous blood glucose monitoring systems, has closed on $13.6 million in Series C financing. The money will go toward clinical trials and regulatory clearance. Investors included Amadeus Capital Partners, Chester Investments, Delta Partners, Morningside Ventures and Frank Bonsal Jr., the company said.

North AmericaUSBriefs